$52.37
0.500.96%
At close: Nov 13, 4:00 PM EST
$52.02
-0.35-0.67%
After Hours: Nov 13, 5:19 PM EST

The average analyst price target for GeneDx Holdings is $87.90, 69.0% above the current price. Of 10 analysts, 9 rate it Buy and 1 Hold. Targets range from $63 to $118. The latest change came on Nov 10, 2026, when BTIG lowered its price target on GeneDx Holdings from $90 to $85 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months